Skip to content

Low or high magnesium concentration in intermittent warm blood cardioplegia in patients undergoing coronary artery surgery: a prospective randomised study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN95530505
Enrollment
400
Registered
2002-04-23
Start date
2001-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischaemic heart disease Circulatory System Ischaemic heart disease

Interventions

Patients will be randomised to: 1. 5 mmol/l Magnesium (Mg2+) 2. 16 mmol/l Mg2+) In the intermittent antegrade warm blood cardioplegia

Sponsors

British Heart Foundation (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. A diagnosis of ischaemic heart disease 2. Undergoing primary myocardial revascularisation with the use of cardiopulmonary bypass and cardioplegic arrest

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026